Sanofi-Aventis Deutschland GmbH
- Pharmaceutical Sales 2010
-
Worldwide: 30.4 billion Euro
In Germany: 4.7 billion Euro (incl. export)
- Product Range
-
Pharmaceuticals for treating cardiovascular diseases, arterial and venous thromboses; pharmaceuticals for oncology, diabetes, infections, allergology, nephrology and internal medicine (incl. urology, muscle and skeletal disorders, thyroid diseases), diseases of the central nervous system, for osteoporosis, arthritis and asthma. Moreover over-the-counter (OTC) and generic pharmaceuticals (Zentiva brand), analgetics and dental drugs.
- Key Research Areas
- Diabetes and metabolic disorders, age-related diseases: musculoskeletal diseases, osteoarthrosis, muscular atrophy (sarcopenia), as well as stroke
- R&D Expenditure 2010
-
Worldwide: 4.4 billion Euro
In Germany: 614 million Euro (associated german companies)
- Employees in the Pharmaceuticals Division 2010
-
Worldwide: ca. 100,000
In Germany: ca. 9,500 (associated german companies)
(All data based on corporate information, as of: 06/2011)
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
Suggest page
Print page
Bookmark page